Alpert, Michael David
- Emmune, Inc (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,532
- Rising Star
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.3M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#1,532
By linked amount among FY2023 PIs
Earliest Year Loaded
2015
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Alpert, Michael David as a PI. Multi-PI records show the full award amount for context.
- 5R44TR003501-03R44Contact PIEngineering AAV capsids for enhanced transduction of skeletal muscle$1Maward amount
- $1Maward amount
- 4R44AI170392-02R44Contact PISARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites$1Maward amount
- $300Kaward amount
Award organization
Organizations that administered FY2023 awards listing Alpert, Michael David as a PI.
FY2023 award administered by Emmune, Inc (FL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardEmmune, Inc
- 2016$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #5289
- 2018$2M Cumulative Funding
- 2018Entered Top 25% NationallyRanked #2275
- 2019$5M Cumulative Funding
- 2022Entered Top 10% NationallyRanked #1578
- 2023$10M Cumulative Funding